KPTI
NASDAQ · Biotechnology
Karyopharm Therapeutics Inc
$6.26
+0.17 (+2.79%)
Open$6.22
Previous Close$6.09
Day High$6.66
Day Low$6.00
52W High$42.72
52W Low$31.53
Volume—
Avg Volume515.0K
Market Cap114.62M
P/E Ratio38.25
EPS$1.03
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+685.0% upside
Current
$6.26
$6.26
Target
$49.14
$49.14
$31.72
$49.14 avg
$61.64
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.41M | 24.30M | 18.75M |
| Net Income | -4,725,651 | -4,467,152 | -3,864,497 |
| Profit Margin | -20.2% | -18.4% | -20.6% |
| EBITDA | -4,842,921 | -5,147,496 | -4,398,523 |
| Free Cash Flow | -2,987,444 | -3,231,735 | -3,403,763 |
| Rev Growth | +9.9% | +18.6% | +24.5% |
| Debt/Equity | 0.51 | 0.75 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |